Movatterモバイル変換


[0]ホーム

URL:


Eurekaselect logo
Bentham Newsletternewsletter banner
Login
Login

Forgot Your Password? New around here? Sign up
Register Cart 0
Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Review Article

Myelin Repair as a Novel Mechanism for Ketamine’s Sustained Antidepressant Effects

Author(s):Sen Wang,Chaoli Huang,Mengyu Wang,Lingxiao Di,Cunming Liu,Kenji Hashimoto* andChun Yang*

Volume 23, Issue 8, 2025

Published on: 16 January, 2025

Page: [943 - 955]Pages: 13

DOI:10.2174/011570159X349856241213144902

Price: $65

TIMBC 2025
Abstract

Depression is a prevalent mental disorder, affecting approximately 300 million peopleworldwide. Despite decades of research into the underlying mechanisms of depression, a consensusremains elusive. Recent studies have implicated changes in oligodendrocytes and myelin in the pathogenesisof depression. Conventional antidepressants may alleviate symptoms within weeks of use,but approximately one-third of patients do not respond to them. Ketamine exhibits rapid and sustainedantidepressant effects in treatment-resistant patients with depression. Given the associationbetween reduced myelination and depression pathology, alterations in myelination may be a keymechanism underlying ketamine's prolonged antidepressant effects. However, the exact role of myelinationin ketamine's sustained antidepressant effects remains unclear. In this review, we summarizethe relationship between demyelination and depression and discuss the potential mechanisms bywhich ketamine may exert its antidepressant effects by repairing myelin damage, offering new insightsinto the role of myelination in antidepressant mechanisms.

Keywords:Arketamine, enantiomer, esketamine, ketamine, depression, myelination, oligodendrocyte.

Graphical Abstract


Rights & PermissionsPrintCite

Current Neuropharmacology

Title:Myelin Repair as a Novel Mechanism for Ketamine’s Sustained Antidepressant Effects

Volume: 23Issue: 8

Author(s):Sen Wang, Chaoli Huang, Mengyu Wang, Lingxiao Di, Cunming Liu, Kenji Hashimoto*Chun Yang*

Affiliation:

            • Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan
            • Department of Anesthesiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

            Keywords:Arketamine, enantiomer, esketamine, ketamine, depression, myelination, oligodendrocyte.

            Abstract: Depression is a prevalent mental disorder, affecting approximately 300 million peopleworldwide. Despite decades of research into the underlying mechanisms of depression, a consensusremains elusive. Recent studies have implicated changes in oligodendrocytes and myelin in the pathogenesisof depression. Conventional antidepressants may alleviate symptoms within weeks of use,but approximately one-third of patients do not respond to them. Ketamine exhibits rapid and sustainedantidepressant effects in treatment-resistant patients with depression. Given the associationbetween reduced myelination and depression pathology, alterations in myelination may be a keymechanism underlying ketamine's prolonged antidepressant effects. However, the exact role of myelinationin ketamine's sustained antidepressant effects remains unclear. In this review, we summarizethe relationship between demyelination and depression and discuss the potential mechanisms bywhich ketamine may exert its antidepressant effects by repairing myelin damage, offering new insightsinto the role of myelination in antidepressant mechanisms.

            Export Options

            About this article

            Cite this article as:

            Wang Sen, Huang Chaoli, Wang Mengyu, Di Lingxiao, Liu Cunming, Hashimoto Kenji*, Yang Chun*, Myelin Repair as a Novel Mechanism for Ketamine’s Sustained Antidepressant Effects, Current Neuropharmacology 2025; 23 (8) .https://dx.doi.org/10.2174/011570159X349856241213144902

            DOI
            https://dx.doi.org/10.2174/011570159X349856241213144902
            Print ISSN
            1570-159X
            Publisher Name
            Bentham Science Publisher
            Online ISSN
            1875-6190

            Call for Papers in Thematic Issues

            31 December, 2025
            Advances in Neuroinflammation and Neuroprotection: Mechanisms and Therapeutic Frontiers

            It offers a comprehensive exploration of neuroinflammatory and neuroprotective pathways that play central roles in a range of neurological disorders, including stroke, traumatic brain injury, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. This issue invites research on the cellular and molecular mechanisms driving neuroinflammation, such as the roles of ...read more


            Guest Editor(s):Dr. Pundru Chandra Shaker Reddy
            31 December, 2025
            Advances in paediatric and adult brain cancers: emerging targets and treatments

            Brain tumors are the most common solid tumors affecting children and adolescents, with up to 5,000 children diagnosed per year. Pediatric brain tumors, because of their location, are often untreatable and their clinical management can cause significant long-term impairment to intellectual and neurological function with epilepsy and neurodegeneration. Other than ...read more


            Guest Editor(s):Dr. Domenico Tricarico
            31 December, 2025
            Cannabinoids in Health and Disease.

            The role of cannabinoids in human physiology and disease has become a dynamic and rapidly evolving field of research, offering new insights into the potential of these compounds. With advancements in neuropharmacology and clinical trials, cannabinoids are now at the forefront of innovative approaches to treat several conditions. This special ...read more


            Guest Editor(s):Dr. Dr. Rui Rodrigues
            20 February, 2026
            Cannabis in Health and Disease

            Cannabis-based products span a history of over 4,000 years, with their regular purposes in numerous religious rituals, traditional systems of medicine, cosmetics, and hedonic activities. The discovery and cloning of cannabinoid receptors in mammalian tissues provided direct evidence of the physiological significance of targeting these receptors with endogenously synthesized and ...read more


            Guest Editor(s):Dr. MD Javed
            Related Journals

            Anti-Cancer Agents in Medicinal Chemistry

            Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

            Current Bioactive Compounds

            Current Cancer Drug Targets

            Combinatorial Chemistry & High Throughput Screening

            Current Cancer Therapy Reviews

            Current Diabetes Reviews

            Current Drug Safety

            Current Drug Targets

            Current Drug Therapy

            Related Books

            Therapeutic Plants: Recent Advances in the Use of Herbs as Alternative Medications

            Quality Assurance of Ethno-Herbals: Cultivating Confidence in Alternative Medicine

            Traditional Medicine in North East Africa: Research on Traditional Healer Preparations and Herbs

            Andrographolide and its Analogs: Botanical Sources, Phytochemistry, Pharmacology, and Biotechnology

            Frontiers in Clinical Drug Research-Dementia

            Anthocyanins: Pharmacology and Nutraceutical Importance

            The Roles and Responsibilities of Clinical Pharmacists in Hospital Settings

            Interventional Pain Surgery

            Endoscopy and Fetoscopy Techniques for the Brain and Neuroaxis

            Bioactive Compounds from Medicinal Plants for Cancer Therapy and Chemoprevention

            Article Metrics
            14
            Wayfinder Image
            TIMBC 2025
            © 2025 Bentham Science Publishers |Privacy Policy

            [8]ページ先頭

            ©2009-2025 Movatter.jp